Ledger.Open graph →

SEC Form D · filed February 19, 2020

ReAlta Life Sciences, Inc

Offering

$2.0M

Sold

—

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

NORFOLK, VA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (32)

Neel Krishna · NORFOLK, VAExec Barry Strasnick · NORFOLK, VADirector John K. Rickman · NORFOLK, VAExec Edward Heidt, Jr · NORFOLK, VAExec · Director Ulrich Thienel · NORFOLK, VAExec · Director Thomas K. Mccarter · NORFOLK, VAExec Frank Gadams · NORFOLK, VADirector Kenji Cunnion · NORFOLK, VAExec · Director Owen Davis · Brooklyn, NYExec Jason Reichl · GREELEY, COExec · Director John Polchin · Lehi, UTExec Sean Hopkins · GREELEY, COExec Scott Neal · GREELEY, CODirector Steve N. Dietlin · Oceanside, CAExec · Director Mark Khuri · BEND, ORDirector Oren N. Shill · Oceanside, CAExec · Director Jonathan Zalevsky · NORFOLK, VADirector Azmi Nabulsi · NORFOLK, VADirector Deborah Geraghty · Lincoln, MADirector Christine Neikirk · NORFOLK, VADirector Greg E. Jensen · Belgrade, MTExec · Director Angela M. Duskey · Youngstown, OHExec · Director John M. O'Donnell · PITTSBURGH, PAExec Douglas A. Nelson, Jr · PITTSBURGH, PADirector Joseph T. Samosky · PITTSBURGH, PAExec · Director Clayton Wood · SEATTLE, WADirector James Wang · SEATTLE, WAExec Yongbai Choi · SEATTLE, WAExec Jonathan Zalevsky · NORFOLK, VADirector Azmi Nabulsi · NORFOLK, VADirector Deborah Geraghty · NORFOLK, VADirector Christine Neikirk · NORFOLK, VADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗